WuXi PharmaTech (Cayman) (NYSE: WX) is one of 186 publicly-traded companies in the “Biotechnology & Medical Research” industry, but how does it weigh in compared to its peers? We will compare WuXi PharmaTech (Cayman) to related businesses based on the strength of its analyst recommendations, dividends, earnings, institutional ownership, risk, valuation and profitability.

Institutional & Insider Ownership

49.7% of shares of all “Biotechnology & Medical Research” companies are owned by institutional investors. 14.5% of shares of all “Biotechnology & Medical Research” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares WuXi PharmaTech (Cayman) and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
WuXi PharmaTech (Cayman) 7.52% 6.93% 4.67%
WuXi PharmaTech (Cayman) Competitors -4,360.38% -480.10% -42.86%

Valuation and Earnings

This table compares WuXi PharmaTech (Cayman) and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
WuXi PharmaTech (Cayman) N/A N/A 38.91
WuXi PharmaTech (Cayman) Competitors $217.40 million -$39.57 million -17.02

WuXi PharmaTech (Cayman)’s peers have higher revenue, but lower earnings than WuXi PharmaTech (Cayman). WuXi PharmaTech (Cayman) is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and target prices for WuXi PharmaTech (Cayman) and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WuXi PharmaTech (Cayman) 0 0 0 0 N/A
WuXi PharmaTech (Cayman) Competitors 559 2515 6752 132 2.65

As a group, “Biotechnology & Medical Research” companies have a potential upside of 14.50%. Given WuXi PharmaTech (Cayman)’s peers higher probable upside, analysts clearly believe WuXi PharmaTech (Cayman) has less favorable growth aspects than its peers.

WuXi PharmaTech (Cayman) Company Profile

WuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.

Receive News & Ratings for WuXi PharmaTech (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi PharmaTech (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.